In 2018, Digital Diagnostics’ flagship product, LumineticsCore™, became the first FDA-cleared AI diagnostic system capable of providing autonomous diagnoses at the point-of-care without the need for physician oversight. LumineticsCore is engineered to identify diabetic retinopathy, a common complication of diabetes and a leading cause of blindness. LumineticsCore has been rigorously validated against patient outcomes in the intended clinical workflow to keep patient safety the main priority. By seamlessly integrating high-quality AI diagnostic capabilities into primary care settings, LumineticsCore can help bridge the gap between specialty and primary care in healthcare delivery. Digital Diagnostics is dedicated to transforming healthcare, starting with the creation one diagnostic system that can positively impact the lives of patients globally.